Detalhe da pesquisa
1.
Peripheral blood stem cell mobilisation following bortezomib, lenalidomide and dexamethasone induction for multiple myeloma: a real-world single-centre experience.
Intern Med J
; 54(1): 108-114, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37357752
2.
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.
Am J Hematol
; 98(2): 272-281, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309981
3.
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.
Blood
; 125(6): 915-23, 2015 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25519749
4.
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Haematologica
; 102(2): 356-363, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28143954
5.
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study.
Blood
; 122(4): 515-22, 2013 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23704092
6.
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Blood
; 120(8): 1570-80; quiz 1752, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22715121
7.
Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials.
BMJ Open
; 14(1): e076246, 2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238183
8.
Ultra-low dose external beam radiotherapy for presumed choroidal lymphoma: a case report.
J Ophthalmic Inflamm Infect
; 12(1): 10, 2022 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247125
9.
Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy.
Leuk Lymphoma
; 62(1): 112-117, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32981406
10.
Cereblon pathway biomarkers and immune profiles in patients with myeloma receiving post-ASCT lenalidomide maintenance (LEOPARD).
Leuk Lymphoma
; 62(12): 2981-2991, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34263697
11.
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.
Blood
; 112(10): 3965-73, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18768781
12.
Lymphoma, a great imitator in neurology.
J Clin Neurosci
; 73: 308-310, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32081598
13.
Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis.
J Clin Oncol
; 38(28): 3252-3260, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730181
14.
The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia.
Leuk Lymphoma
; 60(7): 1796-1802, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30632843
15.
Is dose-adjusted EPOCH-R the new standard for high-risk Burkitt lymphoma?
Lancet Haematol
; 10(12): e942-e943, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922924
16.
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells.
Leukemia
; 32(12): 2572-2579, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30315232
17.
Thrombotic microangiopathy associated with intravenous injection of extended-release oxycodone.
BMJ Case Rep
; 20172017 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28716778
18.
Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML).
Leuk Lymphoma
; 58(2): 298-307, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27268068
19.
Hyperleukocytosis associated with delayed presentation among patients with acute leukemia during the COVID-19 pandemic.
Leuk Lymphoma
; 63(11): 2731-2734, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727162
20.
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy.
Leuk Lymphoma
; 57(5): 1044-53, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26464106